List of serched triples

A total of 22252 records found

#15792 middle Confidence
Subject: Nucleolar_organizer_regions (Nucleolar organizing region)
were_measured_as
Object: argyrophilic_NORs_(AgNORs) (Molecular markers)
Original: Nucleolar organizer regions#were measured as#argyrophilic NORs (AgNORs)
🏥 not_specified 📄 PMID: 9293789
#15791 middle Confidence
Subject: silver_stained_nucleolar_organizer_regions (Nucleolar organizer region)
are_re_evaluated_in
Object: cutaneous_melanocytic_lesions (Tumor phenotype)
Original: Silver-stained nucleolar organizer regions#are re-evaluated in#problematic cutaneous melanocytic lesions
🏥 not_specified 📄 PMID: 1955937
#15790 middle Confidence
Subject: proliferative_activity (Cellular Processes)
was_assessed_using
Object: DNA_flow_cytometry (Flow cytometry)
Original: Proliferative activity#was assessed using#AgNOR staining/ PCNA staining/ and DNA flow cytometry
🏥 not_specified 🧬 PCNA 📄 PMID: 7903955
#15789 middle Confidence
Subject: proliferative_activity (Cellular Processes)
was_assessed_using
Object: PCNA_staining (Dyeing technology)
Original: Proliferative activity#was assessed using#AgNOR staining/ PCNA staining/ and DNA flow cytometry
🏥 not_specified 🧬 PCNA 📄 PMID: 7903955
#15788 middle Confidence
Subject: proliferative_activity (Cellular Processes)
was_assessed_using
Object: AgNOR_staining (Dyeing technology)
Original: Proliferative activity#was assessed using#AgNOR staining/ PCNA staining/ and DNA flow cytometry
🏥 not_specified 🧬 PCNA 📄 PMID: 7903955
#15787 middle Confidence
Subject: AgNOR_biological_significance (Molecular pathology indicators)
was_evaluated_in
Object: primary_adenocarcinomas (Tumor phenotype)
Original: AgNOR biological significance#was evaluated in#colonic adenomas and primary adenocarcinomas
🏥 not_specified 📄 PMID: 1766132
#15786 middle Confidence
Subject: AgNOR_biological_significance (Molecular pathology indicators)
was_evaluated_in
Object: colonic_adenomas (Tumor phenotype)
Original: AgNOR biological significance#was evaluated in#colonic adenomas and primary adenocarcinomas
🏥 not_specified 📄 PMID: 1766132
#15785 middle Confidence
Subject: TSGF (Tumor markers)
was_measured_by
Object: diagnostic_technique (Diagnostic techniques)
Original: CEA/ SCC/ and TSGF#were measured by#various diagnostic techniques
🏥 diagnosis 🧬 CEA/SCC/TSGF 📄 PMID: 15142458
#15784 middle Confidence
Subject: SCC (Tumor markers)
was_measured_by
Object: diagnostic_technique (Diagnostic techniques)
Original: CEA/ SCC/ and TSGF#were measured by#various diagnostic techniques
🏥 diagnosis 🧬 CEA/SCC/TSGF 📄 PMID: 15142458
#15783 middle Confidence
Subject: CEA (Tumor markers)
was_measured_by
Object: diagnostic_technique (Diagnostic techniques)
Original: CEA/ SCC/ and TSGF#were measured by#various diagnostic techniques
🏥 diagnosis 🧬 CEA/SCC/TSGF 📄 PMID: 15142458
#15782 middle Confidence
Subject: AgNOR_expression (Molecular pathology indicators)
was_measured_in
Object: peripheral_blood_T_lymphocytes (Immune cells)
Original: AgNOR expression#was measured in#peripheral blood T lymphocytes of patients with esophageal carcinoma and healthy controls
🏥 not_specified 📄 PMID: 15142458
#15781 middle Confidence
Subject: AgNOR_expression (Molecular pathology indicators)
was_evaluated_in
Object: peripheral_blood_T_lymphocytes (Immune cells)
Original: AgNOR expression#was evaluated in#peripheral blood T lymphocytes of esophageal carcinoma patients
🏥 not_specified 📄 PMID: 15142458
#15780 middle Confidence
Subject: AgNOR_score (Molecular pathology indicators)
is_indicator_of
Object: tumor_size (Tumor phenotype)
Original: AgNOR score#is an indicator of#tumor size
🏥 Diagnostic significance 📄 PMID: 1582501
#15779 middle Confidence
Subject: TNM_staging (Clinical staging)
correlated_to
Object: AgNOR_score (Nucleus-associated molecules)
Original: TNM staging#was correlated to#AgNOR score
🏥 Diagnostic significance 📄 PMID: 1582501
#15778 middle Confidence
Subject: AgNOR_score (Nucleus-associated molecules)
related_to
Object: estrogen_receptor_status (Receptor status)
Original: AgNOR score#was related to#clinical staging and estrogen receptor status in breast carcinoma
🏥 Diagnostic significance 📄 PMID: 1582501
#15777 middle Confidence
Subject: AgNOR_score (Nucleus-associated molecules)
related_to
Object: clinical_staging (Clinical staging)
Original: AgNOR score#was related to#clinical staging and estrogen receptor status in breast carcinoma
🏥 Diagnostic significance 📄 PMID: 1582501
#15776 middle Confidence
Subject: MDM2 (Protein coding genes)
correlates_with
Object: proliferation_index (Cell proliferation markers)
Original: p53 and MDM2 expression#correlates with#tumor grade and proliferation indices
🏥 Prognostic significance 🧬 TP53/MDM2 📄 PMID: 9155045
#15775 middle Confidence
Subject: MDM2 (Protein coding genes)
correlates_with
Object: tumor_grade (Tumor grade)
Original: p53 and MDM2 expression#correlates with#tumor grade and proliferation indices
🏥 Prognostic significance 🧬 TP53/MDM2 📄 PMID: 9155045
#15774 middle Confidence
Subject: TP53 (Protein coding genes)
correlates_with
Object: proliferation_index (Cell proliferation markers)
Original: p53 and MDM2 expression#correlates with#tumor grade and proliferation indices
🏥 Prognostic significance 🧬 TP53/MDM2 📄 PMID: 9155045
#15773 middle Confidence
Subject: TP53 (Protein coding genes)
correlates_with
Object: tumor_grade (Tumor grade)
Original: p53 and MDM2 expression#correlates with#tumor grade and proliferation indices
🏥 Prognostic significance 🧬 TP53/MDM2 📄 PMID: 9155045